advertisement

---

Brugnera M 17

Showing records 1 to 17 | Display all abstracts from Brugnera M

126947 Ketorolac, melatonin and latanoprost tri-loaded PLGA microspheres for neuroprotection in glaucoma
Ana González-Cela-Casamayor M
Drug Delivery 2025; 32: 2484277

---

126833 Disclosing long-term tolerance, efficacy and penetration properties of hyaluronic acid-coated latanoprost-loaded liposomes as chronic glaucoma therapy
Brugnera M; Vicario-de-la-Torre M
Journal of Controlled Release 2025; 379: 730-742

---

126947 Ketorolac, melatonin and latanoprost tri-loaded PLGA microspheres for neuroprotection in glaucoma
Rodrigo MJ
Drug Delivery 2025; 32: 2484277

---

126833 Disclosing long-term tolerance, efficacy and penetration properties of hyaluronic acid-coated latanoprost-loaded liposomes as chronic glaucoma therapy
González-Cela-Casamayor MA
Journal of Controlled Release 2025; 379: 730-742

---

126947 Ketorolac, melatonin and latanoprost tri-loaded PLGA microspheres for neuroprotection in glaucoma
Brugnera M; Munuera I
Drug Delivery 2025; 32: 2484277

---

126833 Disclosing long-term tolerance, efficacy and penetration properties of hyaluronic acid-coated latanoprost-loaded liposomes as chronic glaucoma therapy
González-Fernández FM
Journal of Controlled Release 2025; 379: 730-742

---

126947 Ketorolac, melatonin and latanoprost tri-loaded PLGA microspheres for neuroprotection in glaucoma
Martínez-Rincón T
Drug Delivery 2025; 32: 2484277

---

126833 Disclosing long-term tolerance, efficacy and penetration properties of hyaluronic acid-coated latanoprost-loaded liposomes as chronic glaucoma therapy
Ferraboschi I; Andrés-Guerrero V
Journal of Controlled Release 2025; 379: 730-742

---

126947 Ketorolac, melatonin and latanoprost tri-loaded PLGA microspheres for neuroprotection in glaucoma
Prats-Lluís C; Villacampa P
Drug Delivery 2025; 32: 2484277

---

126833 Disclosing long-term tolerance, efficacy and penetration properties of hyaluronic acid-coated latanoprost-loaded liposomes as chronic glaucoma therapy
Nicoli S
Journal of Controlled Release 2025; 379: 730-742

---

126947 Ketorolac, melatonin and latanoprost tri-loaded PLGA microspheres for neuroprotection in glaucoma
García-Feijoó J
Drug Delivery 2025; 32: 2484277

---

126833 Disclosing long-term tolerance, efficacy and penetration properties of hyaluronic acid-coated latanoprost-loaded liposomes as chronic glaucoma therapy
Sissa C; Pescina S
Journal of Controlled Release 2025; 379: 730-742

---

126947 Ketorolac, melatonin and latanoprost tri-loaded PLGA microspheres for neuroprotection in glaucoma
Pablo LE; Bravo-Osuna I
Drug Delivery 2025; 32: 2484277

---

126833 Disclosing long-term tolerance, efficacy and penetration properties of hyaluronic acid-coated latanoprost-loaded liposomes as chronic glaucoma therapy
Herrero-Vanrell R
Journal of Controlled Release 2025; 379: 730-742

---

126947 Ketorolac, melatonin and latanoprost tri-loaded PLGA microspheres for neuroprotection in glaucoma
García-Martín E
Drug Delivery 2025; 32: 2484277

---

126833 Disclosing long-term tolerance, efficacy and penetration properties of hyaluronic acid-coated latanoprost-loaded liposomes as chronic glaucoma therapy
Bravo-Osuna I
Journal of Controlled Release 2025; 379: 730-742

---

126947 Ketorolac, melatonin and latanoprost tri-loaded PLGA microspheres for neuroprotection in glaucoma
Herrero-Vanrell R
Drug Delivery 2025; 32: 2484277

---